title: Effects of glucose-insulin-potassium solution on acute myocardial infarction outcome in patients received streptokinase according to Killip classes.
authors.affiliation: Department of Cardiology, Tabriz University (Medical Sciences), Tabriz, Eastern Azerbaijan, Iran.
authors.forename: Zeynab
authors.initials: Z
authors.lastname: Soltani
authors.forename: Jahanbakhsh
authors.initials: J
authors.lastname: Samadikhah
authors.forename: Rasoul
authors.initials: R
authors.lastname: Azarfarin
authors.forename: Bahram
authors.initials: B
authors.lastname: Hashemi
authors.forename: Nariman
authors.initials: N
authors.lastname: Nezami
mesh_terms: D002314:Cardioplegic Solutions / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D005947:Glucose / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000145:classification* / Q000188:drug therapy* / Q000401:mortality; D011188:Potassium / Q000627:therapeutic use; D016037:Single-Blind Method; D013300:Streptokinase / Q000627:therapeutic use*
chemical_list: D002314:Cardioplegic Solutions; D005343:Fibrinolytic Agents; D007328:Insulin; C030396:glucose-insulin-potassium cardioplegic solution; D013300:Streptokinase; D005947:Glucose; D011188:Potassium